Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03754218 · ClinicalTrials.gov registry record · Early Phase 1
Amnion Wound Covering for Enhanced Wound Healing
A Early Phase 1 study of Burns and Wound of Skin, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 7
- Enrollment target
- 1
- Study location
NCT03754218 is a Early Phase 1 study of Burns and Wound of Skin that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 7 participants, below the 83-participant average among 36 other Burns trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03754218, a Early Phase 1 study of Burns and Wound of Skin, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 7 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to find our if human amnion membrane powder can be safely used as a covering for wounds and can improve the condition of skin graft donor sites. The amnion powder product is composed of "lyophilized" (freeze-dried), "gamma irradiation sterilized" (exposed to bacteria killing radiation) fragments of amniotic membrane.
Conditions Studied
Interventions
- DRUG Amnion Membrane Powder
- PROCEDURE SOC Wound Covering
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2019-12-01 |
| Est. Completion | 2023-11-22 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03754218
The ClinicalTrials.gov registry entry for NCT03754218 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 83-participant average among 36 other Burns trials with a reported enrollment target (92% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Burns appearing as the primary indexed condition, and to 2 interventions - of which Amnion Membrane Powder is the first listed.
NCT03754218 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT03754218 about?
NCT03754218 is a clinical study titled "Amnion Wound Covering for Enhanced Wound Healing". The purpose of this research study is to find our if human amnion membrane powder can be safely used as a covering for wounds and can improve the condition of skin graft donor sites. The amnion powder product is composed of "lyophilized" (freeze-dried), "gamma irradiation sterilized" (exposed to bac...
What is the current status of trial NCT03754218?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 7 participants. The study started on 2019-12-01. Estimated completion is 2023-11-22.
What conditions does trial NCT03754218 study?
This clinical trial studies the following conditions: Burns, Wound of Skin, Skin Wound.
What interventions are being tested in trial NCT03754218?
The interventions under investigation include: Amnion Membrane Powder (DRUG), SOC Wound Covering (PROCEDURE).
Who is sponsoring clinical trial NCT03754218?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03754218 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Burns
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds
RECRUITING · NA
-
Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain
RECRUITING · Phase 4
-
Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers
RECRUITING · Phase 4
-
Burn Study- Tranexamic Acid Versus Thrombin in Split Thickness Skin Graft
RECRUITING · Phase 4
-
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
RECRUITING · Phase 2
-
Impact of a Telerehabilitation Program With Technology Enhancement on Post-burn Recovery
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.